Skip to menu Skip to content Skip to footer

An early phase, open label, multi-centre trial of front-line TheRapy for EBv-associated Lymphomas -- 2: TREBL-2 (Stream 6) (2022-2027)

Experts

Professor Maher Gandhi

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Maher Gandhi
Maher Gandhi

Associate Professor Colm Keane

Principal Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Colm Keane